Cervical cancer is the name for cancer that starts in the cells of the cervix. The smaller, lower end of the uterus is called the cervix (womb). The birth canal, or vagina, is joined to the uterus by the cervix. Typically, cervical cancer progresses gradually over time. Prior to cervical cancer developing, dysplasia a condition in which abnormal cells start to grow in the cervical tissue occurs in the cervix's cells. The abnormal cells may eventually develop into cancer cells and begin to expand and spread more into the cervix and surrounding tissues if they are not eliminated or killed.
There are currently vaccinations against virus strains that cause cancer. By strengthening the body's defences against HPV and assisting in its removal, this vaccine helps stop cancer from developing.
The human papillomavirus, or HPV, is transmitted during intercourse. Genital warts are caused by certain HPV strains. Cancers can be caused by other HPV strains. Usually, the body can recognize and get clear of HPV. However, cancer could develop if the virus stays in the body for a long time. Both men and women can prevent cancer by receiving an HPV vaccination.
Most occurrences of cervical cancer and genital warts are prevented with the HPV vaccine. It guards against HPV-related cancer of the vagina, vulva, penis, or anus. Additionally, the HPV vaccine guards against HPV-related cancers of the mouth, throat, head, and neck.
The vaccine provides the body with a safe means of introducing certain HPV strains into the immune system. This implies that if a person contracts such strains of the virus later, their body will have an easier difficulty getting rid of them.
The U.S. Food and Drug Administration (FDA) has granted licences for three HPV vaccines: the bivalent HPV vaccine (Cervarix, 2vHPV), the quadrivalent HPV vaccine (Gardasil, 4vHPV), and the 9-valent HPV vaccine (Gardasil 9, 9vHPV). Most HPV cancers are caused by HPV types 16 and 18, which are protected against by all three HPV vaccinations.
In the US, only Gardasil-9 (9vHPV) has been available for distribution since late 2016. Nine HPV types are protected against by this vaccine: 6, 11, 16, 18, 31, 33, 45, 52, and 58.
Age 11 and 12 are the suggested times for HPV vaccination. Vaccination against HPV can begin as early as age 9. In order to protect themselves from HPV infections that may result in cancer in the future, all preteens must have the HPV vaccination.
HPV vaccination is also necessary for teenagers and young people up to the age of 26 who did not begin or complete the HPV immunisation series.
Certain people shouldn't receive HPV vaccinations if:
They had a possible dangerous allergic reaction to any component of an HPV vaccine or to an earlier HPV vaccination dosage.
They (Gardasil and Gardasil 9) are allergic to fungus.
They had a baby.
Those who are seriously or moderately ill need to hold off until they get better.
Doctor's offices, community health centres, school-based health centres, and health agencies may offer the HPV vaccine.
The World Health Organization advises, as of late 2022, that females between the ages of 9 and 14 should take one or two doses each day.
A one- or two-dose regimen for women and girls between the age of 15 and 20.
For women over 21, two doses separated six months away.
In India, cervical cancer is the leading cause of death for women, there is a need for a cervical cancer vaccination that is both affordable and effective. Don’t forget to get our daughters, wives and mothers vaccinated. The right age is 9 to 15 years of age. It is only three doses and it is very very safe. There are no side-effects and today is the right time for further enquiries contact us for more details Ashakiran Hospital